Literature DB >> 2434803

An evaluation of routine follow-up for detection of breast cancer recurrences.

A Zwaveling, G H Albers, W Felthuis, J Hermans.   

Abstract

Four hundred patients who were radically treated for breast carcinoma during the period May 1974 to December 1980 were followed for a minimum of 4 years. The outcomes of the 128 patients with recurrences were studied. A differentiation into two groups was made: those in whom recurrences were detected as a real result of follow-up (27%) and those in whom this was not the case (73%). Both groups were comparable as regards age, period "at risk," nature and site of recurrence, type of therapy instituted, and their response to it. No differences could be found in any of these factors. The recurrence-free interval, the survival after institution of therapy, and the total survival after the primary procedure were the same in both groups.

Entities:  

Mesh:

Year:  1987        PMID: 2434803     DOI: 10.1002/jso.2930340314

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  12 in total

1.  Quality of post-treatment surveillance of early stage breast cancer in Texas.

Authors:  Abhishek D Parmar; Kristin M Sheffield; Gabriela M Vargas; Yimei Han; Celia Chao; Taylor S Riall
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

2.  Routine follow up of breast cancer in primary care: randomised trial.

Authors:  E Grunfeld; D Mant; P Yudkin; R Adewuyi-Dalton; D Cole; J Stewart; R Fitzpatrick; M Vessey
Journal:  BMJ       Date:  1996-09-14

3.  Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Authors:  Sweet Ping Ng; Courtney Pollard; Joel Berends; Zeina Ayoub; Mona Kamal; Adam S Garden; Houda Bahig; Scott B Cantor; Andrew J Schaefer; Temitayo Ajayi; G Brandon Gunn; Steven J Frank; Heath Skinner; Jack Phan; William H Morrison; Renata Ferrarotto; Jason M Johnson; Abdallah S R Mohamed; Stephen Y Lai; Amy C Hessel; Erich M Sturgis; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

Review 4.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

5.  Clinical surveillance for early stage breast cancer: an analysis of claims data.

Authors:  M S Simon; M Stano; R K Severson; M S Hoff; D W Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  A survey of the management of breast cancer in England and Wales.

Authors:  S A Harries; R N Lawrence; R Scrivener; N R Fieldman; M W Kissin
Journal:  Ann R Coll Surg Engl       Date:  1996-05       Impact factor: 1.891

7.  Breast cancer surveillance--a cost-effective strategy.

Authors:  D V Schapira
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology.

Authors:  M S Simon; M Hoff; M Hussein; S Martino; A Walt
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

9.  Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: value of sequential imaging in predicting outcome.

Authors:  M J Janicek; K Shaffer
Journal:  Skeletal Radiol       Date:  1995-11       Impact factor: 2.199

10.  Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.

Authors:  M Gion; M Plebani; R Mione; C Penzo; S Meo; A Burlina
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.